Skip to main content
Go to the University of Minnesota Twin Cities home page
  • One Stop
  • MyU: For Students, Faculty, and Staff

Midwest Antiviral Drug Discovery (AViDD) Center

Menu

Breadcrumb

  1. Home

nanosota, nanobody, Midwest AViDD Center, Fang Li, Omicron

University of Minnesota Scientists Develop Novel Antiviral Strategies to Stay Ahead of Evolving COVID-19

Published on 2024-11-26 by kotos001

Subscribe to nanosota, nanobody, Midwest AViDD Center, Fang Li, Omicron

 

Follow Us on Social Media:

 

AViDD Twitter
Twitter

 

 

AViDD Facebook
Facebook

 

 

AViDD LinkedIn
LinkedIn

 

For Students, Faculty, and Staff

  • One Stop
  • MyU: For Students, Faculty, and Staff
© 2026 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement Report Web Accessibility Issues
  • Our Mission
  • News
    • Blog
  • Events & Announcements
  • Research
    • Research Overview
    • Project 1: Small Molecule Entry Inhibitors of Pandemic Viruses
    • Project 2: Nanobodies as Novel Entry Inhibitors of Pandemic Viruses
    • Project 3: Pandemic Virus Protease Inhibitors
    • Project 4: Nuclease Inhibitors for Viruses of Pandemic Concern
    • Project 5: Pandemic Virus Helicase Inhibitors
    • Developmental Research Projects and Mentored Projects
  • Cores
    • Core A: Administration
    • Core B: Antiviral Drug Discovery and Development
    • Core C: Medicinal Chemistry, Drug Metabolism and Pharmacokinetics
    • Core D: Structural and Computational Virology
    • Core E: Cellular and Organismic Systems for Antiviral Testing
  • Publications
    • Publication Summaries
  • Resources
  • Viruses of AViDD Concern
    • Lassa
    • SARS-CoV-2
    • Ebola
    • Zika
  • Our People
  • Contact Us